Article
Novel plasma exosome biomarkers for prostate cancer progression in co-morbid metabolic disease
2022-02-04
Abstract excerpt
Comorbid Type 2 diabetes (T2D), a metabolic complication of obesity, associates with worse cancer outcomes for prostate, breast, head and neck, colorectal and several other solid tumors. However, the molecular mechanisms remain poorly understood. Emerging evidence shows that exosomes carry miRNAs in blood that encode the metabolic status of originating tissues and deliver their cargo to target tissues to modulate...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7dd69308-0b29-5059-b4a5-19b97d3366e7
- DOI
- 10.1101/2022.02.01.478722
